Kiora Pharmaceuticals (KPRX) Total Debt (2016 - 2023)
Kiora Pharmaceuticals' (KPRX) quarterly Total Debt came in at $495000.0 in Q3 2023, up 57.79% YoY from $313714.0 in Q3 2022, and up 57.72% on a QoQ basis from $313853.0 in Q2 2023.
Kiora Pharmaceuticals (KPRX) Total Debt (2016 - 2023) Analysis & Trends
Kiora Pharmaceuticals (KPRX) has 5 years of Total Debt data on file, last reported at $495000.0 in Q3 2023.
- Quarterly Total Debt rose 57.79% year-over-year to $495000.0 in Q3 2023, while the trailing twelve-month figure through Sep 2023 was $495000.0 (up 57.79% YoY) and the FY2022 annual result came in at $322385.0, changed N/A from the prior year.
- Total Debt advanced to $495000.0 in Q3 2023, from $313853.0 in the prior quarter.
- In the past five years, Total Debt ranged from a high of $495000.0 in Q3 2023 to a low of $278190.0 in Q2 2020.
- A 4-year average of $315160.5 and a median of $301808.0 in 2022 frame the typical range for Total Debt.
- The widest YoY moves for Total Debt: up 57.79% in 2023, down 3.99% in 2023.
- Tracing KPRX's Total Debt over 4 years: stood at $278190.0 in 2020, then changed by 0.0% to $278190.0 in 2021, then increased by 15.89% to $322385.0 in 2022, then surged by 53.54% to $495000.0 in 2023.
- The last three Total Debt figures came in at $495000.0 (Q3 2023), $313853.0 (Q2 2023), and $313299.0 (Q1 2023), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.29 Bn | 131.44 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 86.31 Bn | 78.32 Bn | 3.93 Bn | 1.99 Bn |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.92 Bn | 53.78 Bn | 52.00 Mn | 591.00 Mn |
| 5 | BeOne Medicines | 42.07 Bn | 36.97 Bn | 1.53 Bn | 1.07 Bn |
| 6 | Alnylam Pharmaceuticals | 31.70 Bn | 28.39 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 27.99 Bn | 9.60 Bn | 668.28 Mn | 770.36 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 546.77 Mn |
| 9 | Royalty Pharma | 27.28 Bn | 26.45 Bn | - | 9.34 Bn |
| 10 | Kiora Pharmaceuticals | 16.25 Mn | 16.25 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 495,000.00 |
| Jun 30, 2023 | 313,853.00 |
| Mar 31, 2023 | 313,299.00 |
| Dec 31, 2022 | 322,385.00 |
| Sep 30, 2022 | 313,714.00 |
| Jun 30, 2022 | 301,808.00 |
| Mar 31, 2022 | 293,947.00 |
| Mar 31, 2021 | 278,190.00 |
| Dec 31, 2020 | 278,190.00 |
| Sep 30, 2020 | 278,190.00 |
| Jun 30, 2020 | 278,190.00 |
| Mar 31, 2016 | 1.21 Mn |